- Home
- QNST vs CLDX Comparison
QNST vs CLDX Comparison
Compare QNST & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNST
- CLDX
- Stock Information
- Founded
- QNST 1999
- CLDX N/A
- Country
- QNST United States
- CLDX United States
- Employees
- QNST N/A
- CLDX N/A
- Industry
- QNST Business Services
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- QNST Consumer Discretionary
- CLDX Health Care
- Exchange
- QNST Nasdaq
- CLDX Nasdaq
- Market Cap
- QNST 1.1B
- CLDX 1.3B
- IPO Year
- QNST 2010
- CLDX 2008
- Fundamental
- Price
- QNST $14.86
- CLDX $18.33
- Analyst Decision
- QNST Strong Buy
- CLDX Buy
- Analyst Count
- QNST 7
- CLDX 9
- Target Price
- QNST $28.29
- CLDX $50.75
- AVG Volume (30 Days)
- QNST 719.8K
- CLDX 683.3K
- Earning Date
- QNST 05-07-2025
- CLDX 05-08-2025
- Dividend Yield
- QNST N/A
- CLDX N/A
- EPS Growth
- QNST N/A
- CLDX N/A
- EPS
- QNST N/A
- CLDX N/A
- Revenue
- QNST $1,029,978,000.00
- CLDX $7,559,000.00
- Revenue This Year
- QNST $80.76
- CLDX N/A
- Revenue Next Year
- QNST $9.11
- CLDX N/A
- P/E Ratio
- QNST N/A
- CLDX N/A
- Revenue Growth
- QNST 88.81
- CLDX 24.49
- 52 Week Low
- QNST $14.39
- CLDX $14.40
- 52 Week High
- QNST $26.27
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- QNST 35.68
- CLDX 44.29
- Support Level
- QNST $17.72
- CLDX $17.85
- Resistance Level
- QNST $19.29
- CLDX $21.23
- Average True Range (ATR)
- QNST 0.83
- CLDX 1.12
- MACD
- QNST -0.12
- CLDX -0.09
- Stochastic Oscillator
- QNST 3.80
- CLDX 12.87
About QNST QuinStreet Inc.
QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.